None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1st step [retrospective cohorts] ? adult (at least 19 years) acute leukemia patients ? acute leukmia according to WHO classification (WHO 2016) ? patients with available medical records 2nd step (patients) [prospective cohorts] ? adult (at least 19 years) acute leukemia patients ? newly diagnosed acute leukmia according to WHO classification (WHO 2016) ? who willing to participate in this prospective cohort study and to agree to provide additional PB and/or BM sample during the routine diagnostic or treatment procedure 2nd step (healthy donors) [prospective cohorts] ? family donors who will donate their PB or BM to their family patients ? who willing to participate in this prospective cohort study and to agree to provide additional PB and/or BM sample during the routine treatment procedure
Exclusion criteria
Exclusion criteria: 1st step [retrospective cohorts] ? patients with no available medical records 2nd step [prospective cohorts] ? patients: who do not want to participate in this clinical trial and do not want to provide additional PB and/or BM sample ? healthy donors: who do not want to participate in this clinical trial and do not want to provide additional PB and/or BM sample
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical outcomes (remission, relapse, survival, complications after chemotherapy and/or transplantation) and relevant characteristics (patients' character, disease character, biomarker) | — |
Secondary
| Measure | Time frame |
|---|---|
| biomarkers for prediction of clinical outcomes | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea